Other complications As measured by clinical methods · patients undergoing parotidectomy
Acellular dermal matrix may leads to higher other complications As measured by clinical methods compared with control (low certainty).
1 finding from 1 review
Resource implications (e.g. cost of incontinence management methods) · children aged 3 to 17 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 16 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 16 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5 to 15 years with dysfunctional elimination syndrome, 41/59 with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 3 to 18 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 5‐14 years with daytime urinary incontinence or post‐micturition dribbling
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource implications (e.g. cost of incontinence management methods) · children aged 4 to 17 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of sleep · people with CKD
It is very uncertain whether summary of findings: exercise changes sleep quality PSQI, ESS and tri‐axial accelerometer (median compared with control (very low certainty).
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Productivity or work performance Method: total number of documents entered per day, or keystrokes per hour, or WRFQ · office workers
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Productivity or work performance Method: number of words typed per 3 hours · office workers
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Productivity or work performance Method: number of words typed per 3 hours · office workers
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Participant‐reported musculoskeletal pain, discomfort or fatigue Method: 0‐100 mm VAS · office workers
1 finding from 1 review
Antibody response (geometric mean titre) · 9‐ to 14‐year‐old females and males
1 finding from 1 review
VSC: methyl mercaptan · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
Pycnogenol chewing gum showed no clear difference in VSC: methyl mercaptan compared with placebo chewing gum; GRADE not reported.
1 finding from 1 review